Application YC di Trestle Biotherapeutics

Winter 2021Active

Trestle Biotherapeutics ha partecipato a Y Combinator nel batch Winter 2021 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Winter 2021
Settore: HealthcareIndustrial Bio
Dimensione team: 2
Stato: Active
Lanciata: 2021

Founder

Ben ShepherdFounder
Alice ChenFounder

Cosa fa Trestle Biotherapeutics

We are developing an implantable therapeutic tissue that will be surgically delivered to patients suffering from end stage renal disease. Upon implantation, this tissue will supplement the patient's renal function, eliminating their dependency on dialysis and improving their disease status. This has the potential to not only get these patients off dialysis - a significant impact for them and their families - but to greatly extend the time required before kidney transplantation is essential.

Application YC di Trestle Biotherapeutics, ricostruita

Domanda per Y Combinator

Trestle Biotherapeutics, batch Winter 2021. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Trestle Biotherapeutics

Describe what your company does in 50 characters or less.

Bioengineered kidneys for kidney failure

What is your company going to make? Please describe your product and what it does or will do.

We are building an implantable tissue that supplements kidney function for patients with end stage renal disease. Once implanted, it reduces or eliminates their need for dialysis and delays the time until transplantation is necessary.

Where do you live now, and where would the company be based after YC?

We currently live in San Diego, CA. After YC, we plan to keep the company based here to maintain close ties to our research partners and clinical collaborators.

Explain your decision regarding location.

San Diego is a biotech hub with strong academic and clinical resources. Being here lets us work closely with surgeons and researchers to develop an implantable kidney tissue tailored for patients.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Trestle Biotherapeutics?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Trestle Biotherapeutics (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Trestle Biotherapeutics si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Trestle Biotherapeutics?

Trestle Biotherapeutics apparteneva al batch Winter 2021 di Y Combinator.

Chi ha fondato Trestle Biotherapeutics?

Trestle Biotherapeutics è stato fondato da Ben Shepherd, Alice Chen.

Cosa fa Trestle Biotherapeutics?

Bioengineered kidneys for patients with kidney failure

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Trestle Biotherapeutics, e di ogni altro batch YC, è in YC Insights.